Category
17 articles
A tiny angel check feels like validation until you realize it came with a board seat or observer rights that outlive the relationship. Here's how a minor early investor can hijack your Series A — and what to offer instead.
Every inactive angel on your cap table is a small liability that compounds at Series A. Here's how lead investors actually price dead equity, when buybacks happen, and the diligence to run before you cash a single angel check.
Landing your first term sheet feels like winning the lottery — until a second one shows up and you realize you have no idea how to juggle both. Here's the honest timeline, the scripts, and the unforced errors that turn two eager investors into zero.
Founders raising $150K-$300K keep swiping templates built for $3M seed rounds — and it shows. Here's how the deck itself should shrink, shift, and get honest when you're asking for less.
Demo days promise a concentrated room full of capital, but the reality is 50 companies competing for the same 30 check-writers who see every pitch back-to-back. Here's why batch-based raising produces terrible conversion — and the 90-day recovery plan that actually closes rounds.
Most first-time founders skim a term sheet, celebrate the valuation, and sign whatever their lawyer waves through. But the clauses that actually hurt you — drag-along, pay-to-play, redemption rights — rarely announce themselves. Here's the risk ranking your attorney should be giving you, plus the five questions you're not asking.
Most founders go dark when things get ugly, and that's exactly when silence costs them their next round. Here's how to write the update nobody wants to send — what to disclose, what to frame, and which number to lead with.
Most founders treat investor updates as homework. Done right, that monthly email is the cheapest, most effective pre-marketing your next round will ever get. Here's what to send, what to cut, and why the investors who passed are your best subscribers.
Raising 'two years of runway' sounds like a cushion, but the math behind it usually buys you far less breathing room than founders think. Here's how to stress-test your runway against real hiring plans, slow revenue, and the Series A clock.
Most founders treat the SAFE cap as a throwaway number — something to negotiate in five minutes so they can get back to building. But that figure becomes the reference point your Series A investors will use to price your company, and picking the wrong one can trap you in down-round territory before you've even raised a priced round.
Investors can smell a raise that started out of panic. Here's the 90-day audit that turns your finances, metrics, and pitch into something fundable before the first intro goes out.
Investors almost never say no outright — they say things that sound like maybes. Here's a working translation of the most common soft passes, plus a triage system for deciding which conversations to revive and which to bury.
Most founders treat cold outreach like a lottery ticket when they should treat it like a sales pipeline. We crunched the numbers on where leads actually die — and it's rarely the first email.
Most founders treat a raise like a vibe. Treat it like a project plan instead. Here's the week-by-week breakdown from decision day to money in the bank — and where each phase tends to fall apart.
"Just get warm intros" is the most useless advice in fundraising if you didn't go to Stanford or work at Google. Here's what actually makes cold outreach work, with templates you can send this afternoon.
Investors rarely hand you a clean 'no' — they hand you a soft phrase and hope you do the math. Here's a field guide to decoding the nine most common non-answers, plus the follow-up rule that separates founders who close from founders who wait by the phone.
Most founders think a deck and a demo get the check. Wrong. Here's the unglamorous diligence list seed investors actually run — and the six items that quietly kill more pre-seed deals than bad traction ever will.